Tiger Brokers

ETF热点解读|AI赋能引爆CRO上涨，港股医疗ETF、港股通医疗ETF、港股通创新药ETF、恒生生物科技ETF涨超2%

格隆汇
Yesterday
港股市场CRO概念股集体上涨，其中，金斯瑞生物科技大涨超15%，凯莱英、泰格医药、昭衍新药涨超4%，药明康德、信达生物、三生制药涨超2%。 港股通医疗及创新药类ETF集体走强，港股医疗ETF永赢涨2.76%，港股通医疗ETF易方达涨2.73%，港股通医疗ETF工银涨2.35%，港股通医疗ETF汇添富涨2.28%，港股通医疗ETF嘉实涨2.24%，港股医疗ETF银华涨2.23%，港股通医疗ETF华宝涨2.11%，港股通创新药ETF万家涨2.09%，恒生生物科技ETF鹏华涨2.08%，港股创新药ETF广发涨2.06%，港股通创新药ETF富国涨2.04%，恒生生物科技ETF国泰涨2%。 消息面上，诺和诺德与Anthropic宣布达成合作，双方将利用Anthropic的人工智能(AI)模型及Claude Science支持药物发现与研发。有分析指出，诺和诺德联手AI巨头Anthropic(利用Claude推进药物发现)等重磅合作落地，催化了“AI+医药研发”的想象空间，提高了市场对CRO研发效率提升和新技术订单增量的信心。 另外，个股消息面上，金斯瑞生物科技宣布与全球领先制药企业礼来公司的AI/机器学习药物发现协作平台Lilly TuneLab达成合作。根据协议，金斯瑞将向Lilly TuneLab参与企业提供湿实验服务，助力其快速生成实验数据，将AI预测转化为生物学验证数据，加速候选药物评估。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10